Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omeros Corp (OMER)
NASDAQ:OMER
Holding OMER?
Track your performance easily
OMER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.61 - $12.65
Previous Close$7.63
Volume559.38K
Average Volume (3M)757.01K
Market Cap
$442.16M
Enterprise Value$508.46M
Total Cash (Recent Filing)$123.16M
Total Debt (Recent Filing)$189.46M
Price to Earnings (P/E)―
Beta2.58
Next Earnings
Feb 26, 2025EPS Estimate
-$0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.30
Shares Outstanding57,949,760
10 Day Avg. Volume765,243
30 Day Avg. Volume757,007
Standard Deviation0.35
R-Squared0.09
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.87
Price to Sales (P/S)292.43
Price to Cash Flow (P/CF)-3.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue452.37
Enterprise Value/Gross Profit338.97
Enterprise Value/Ebitda-3.20
Forecast
1Y Price Target
$9.00Price Target Upside18.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Omeros News
PremiumCompany Announcements
Omeros Corporation Q3 2024 Financial Results Reviewed
Ownership Overview
9.70%
Insiders
8.70% Mutual Funds
9.20% Other Institutional Investors
61.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMER FAQ
What was Omeros Corp’s price range in the past 12 months?
Omeros Corp lowest stock price was $2.61 and its highest was $12.65 in the past 12 months.
What is Omeros Corp’s market cap?
Currently, no data Available
When is Omeros Corp’s upcoming earnings report date?
Omeros Corp’s upcoming earnings report date is Feb 26, 2025 which is in 67 days.
How were Omeros Corp’s earnings last quarter?
Omeros Corp released its earnings results on Nov 13, 2024. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.705 by $0.145.
Is Omeros Corp overvalued?
According to Wall Street analysts Omeros Corp’s price is currently Undervalued.
Does Omeros Corp pay dividends?
Omeros Corp does not currently pay dividends.
What is Omeros Corp’s EPS estimate?
Omeros Corp’s EPS estimate is -$0.76.
How many shares outstanding does Omeros Corp have?
Omeros Corp has 57,949,760 shares outstanding.
What happened to Omeros Corp’s price movement after its last earnings report?
Omeros Corp reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.705. Following the earnings report the stock price went up 65.871%.
Which hedge fund is a major shareholder of Omeros Corp?
Among the largest hedge funds holding Omeros Corp’s share is Sheaff Brock Investment Advisors LLC. It holds Omeros Corp’s shares valued at N/A.
---
Omeros Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (18.58% Upside)
$9.00 (18.58% Upside)
Blogger Sentiment
Bullish
OMER Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 60.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
167.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-36.45%
Trailing 12-Months
Company Description
Omeros Corp
Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
---
OMER Earnings Call
Q3 2024
0:00 / 0:00
---
OMER Stock 12 Month Forecast
Average Price Target
$9.00
▲(18.58% Upside)
Technical Analysis
ACADIA Pharmaceuticals
―
Corcept Therapeutics
―
RedHill Biopharma
―
Cassava Sciences
―
Best Analysts Covering OMER
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+69.61%
reiterated a buy rating 9 months ago
Copying Stephen Brozak's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +69.61% per trade.
---